XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current assets    
Cash and cash equivalents $ 2,164us-gaap_CashAndCashEquivalentsAtCarryingValue $ 6,258us-gaap_CashAndCashEquivalentsAtCarryingValue
Other current assets 555us-gaap_OtherAssetsCurrent 233us-gaap_OtherAssetsCurrent
Total current assets 2,719us-gaap_AssetsCurrent 6,491us-gaap_AssetsCurrent
Patent license rights, net 666us-gaap_FiniteLivedIntangibleAssetsNet 823us-gaap_FiniteLivedIntangibleAssetsNet
Furniture and equipment, net 0us-gaap_PropertyPlantAndEquipmentNet 3us-gaap_PropertyPlantAndEquipmentNet
Total assets 3,385us-gaap_Assets 7,317us-gaap_Assets
Current liabilities    
Accounts payable 124us-gaap_AccountsPayableCurrent 88us-gaap_AccountsPayableCurrent
Other accrued liabilities 158us-gaap_AccruedLiabilitiesCurrent 12us-gaap_AccruedLiabilitiesCurrent
Total current liabilities 282us-gaap_LiabilitiesCurrent 100us-gaap_LiabilitiesCurrent
Capstone Therapeutics Corp. Stockholders' Equity    
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares outstanding in 2014 and 2013 20us-gaap_CommonStockValue 20us-gaap_CommonStockValue
Additional paid-in capital 189,268us-gaap_AdditionalPaidInCapitalCommonStock 189,215us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated deficit (186,185)us-gaap_RetainedEarningsAccumulatedDeficit (182,018)us-gaap_RetainedEarningsAccumulatedDeficit
Total Capstone Therapeutics Corp. stockholders' equity 3,103us-gaap_StockholdersEquity 7,217us-gaap_StockholdersEquity
Noncontrolling interest 0us-gaap_MinorityInterest 0us-gaap_MinorityInterest
Total equity 3,103us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 7,217us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Total liabilities and equity $ 3,385us-gaap_LiabilitiesAndStockholdersEquity $ 7,317us-gaap_LiabilitiesAndStockholdersEquity